Is remdesivir safe in patients with renal impairment? Experience at a large tertiary urban medical center

por Sunny, Subin, Samaroo-Campbell, Jevon, Abdallah, Marie, Luka, Alla, Quale, John
Publicado 2022

Comparison of Tocilizumab vs Baricitinib in Clinical Outcomes Among Hospitalized Patients With COVID-19: Experience From a Public Hospital System in New York City

por Sunny, Subin, Tran, Ami, Lee, Jennifer, Abdallah, Marie, Chaudhry, Nimra, Quale, John
Publicado 2023

Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies

por Kaminski, Monica A., Sunny, Subin, Balabayova, Khayala, Kaur, Avneet, Gupta, Aanchal, Abdallah, Marie, Quale, John
Publicado 2020

Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022

por Lee, Jennifer, Sunny, Subin, Nazarian, Elizabeth, Fornek, Mary, Abdallah, Marie, Episcopia, Briana, Rowlinson, Marie-Claire, Quale, John
Publicado 2023